Should we stop taking thiazides to prevent kidney stones?

Published Date: 08 Mar 2023

"Thiazide is the standard treatment for calcium stones, so this [new research] has the potential to upset the basket," one observer said.

Read Full News

Latest News

Biomarkers May Guide Tailored Interventions in Obesity

Nutritional and metabolic biomarkers may aid in the early detection of obesity risk, guide precise interventions, and support tailored diets to improve metabolic health.

Gastric Bypass Leads to Diabetes Remission

Laparoscopic one anastomosis gastric bypass achieves sustained diabetes remission in most patients with type 2 diabetes and obesity over 10 years of follow-up.

Oral Acromegaly Drug Performing Well in First Few Patients

Initial real-world results of patients receiving paltusotine suggest reduced symptoms and good tolerability, while a phase 3 trial finds no interaction with levothyroxine.

Gastric Ring Add-On May Aid Weight Loss After Surgery

A ring-augmented one anastomosis gastric bypass achieves greater weight loss than standard surgery in patients with recurrent weight gain or suboptimal outcomes after sleeve gastrectomy.

MASLD Risk May Be Higher in Men Who Eat More Red Meat

Red meat intake showed no overall association with MASLD risk, but higher daily consumption (75-90 g) was linked to increased risk in men.

Childhood Trauma Tied to Gestational Diabetes Risk

Women with prior adverse childhood experiences may face a higher risk for gestational diabetes, with the risk rising with each additional adverse experience, a meta-analysis of 11 studies shows.

Todays Updates

Baveno Criteria May Reduce Endoscopy Burden in Cirrhosis

The Baveno VI criteria show high sensitivity for ruling out clinically significant portal hypertension and high-risk varices in patients with cirrhosis.

Todays Updates

Baveno Criteria May Reduce Endoscopy Burden in Cirrhosis

The Baveno VI criteria show high sensitivity for ruling out clinically significant portal hypertension and high-risk varices in patients with cirrhosis.

Latest News

Nutritional and metabolic biomarkers may aid in the early detection of obesity risk, guide precise interventions, and support tailored diets to improve metabolic health.

Laparoscopic one anastomosis gastric bypass achieves sustained diabetes remission in most patients with type 2 diabetes and obesity over 10 years of follow-up.

Initial real-world results of patients receiving paltusotine suggest reduced symptoms and good tolerability, while a phase 3 trial finds no interaction with levothyroxine.

A ring-augmented one anastomosis gastric bypass achieves greater weight loss than standard surgery in patients with recurrent weight gain or suboptimal outcomes after sleeve gastrectomy.

Red meat intake showed no overall association with MASLD risk, but higher daily consumption (75-90 g) was linked to increased risk in men.

Women with prior adverse childhood experiences may face a higher risk for gestational diabetes, with the risk rising with each additional adverse experience, a meta-analysis of 11 studies shows.

News All Time

Brolucizumab Beats Laser Treatment in Diabetic Retinopathy

Intravitreal brolucizumab is superior to panretinal laser photocoagulation in preserving visual acuity for patients with proliferative diabetic retinopathy, clinical trial data show.

Boehringer-Zealand Drug Leads to 16.6% Weight Loss in Late-stage Trial

Boehringer Ingelheim said on Tuesday its experimental obesity drug led to average weight loss of up to 16.6% in ⁠a late-stage trial, as the unlisted German drugmaker seeks...

Mobile App for Hand Osteoarthritis Improves Pain, Function

Though currently available only in Norwegian, the researchers are expanding the app to more languages, including English.

Low Obesity-Related QOL Motivates Kids Weight Management

Families may be more motivated to participate in a pediatric weight management program when children and adolescents experience lower obesity-related quality of life.

Women With Acromegaly Face Greater Disease Burden Than Men

Women with acromegaly experience a significantly higher disease burden and poorer physical and mental quality of life than men.

OA, Knee Replacement Risk Highest With Sarcopenic Obesity

The findings suggest that resistance training is an important adjunct to other exercise for patients with knee osteoarthritis.

Can AI Ease Clinician-Patient Conversations About Obesity?

The Obesity Medicine Association’s interactive tool was designed to help clinicians practice real-world obesity-care discussions ‘grounded in science and compassion.’

Is It Time to Abandon Stepwise Escalation for Diabetes?

Evidence lends credence to the idea of starting multiple approaches faster, earlier for type 2 diabetes.

Is Treatment-Resistant Obesity Affecting Your Patients?

Are your midlife female patients experiencing treatment-resistant obesity?

Remote Culinary Coaching Can Drive Weight Loss in Obesity

A remote culinary medicine program combining cooking and health coaching leads to an average weight loss of more than 4% at 1 year in adults with overweight and obesity.

EMA Pushes Earlier Intervention in Rare Pediatric Diseases

The EMA has backed broader pediatric use of Agamree and Crysvita, lowering age thresholds for rare genetic diseases affecting muscle and bone development.

Insulin-Requiring Diabetes Tied to Higher Risk for Dementia

Diabetes, especially type 1 and insulin-treated type 2, is significantly associated with an increased risk for all-cause dementia, Alzheimer’s disease, and vascular dementia, a cohort study finds.

Heated Tobacco Linked to T2D Risk as Much as Cigarettes

Individuals who only use heated tobacco products do not have a lower risk for type 2 diabetes than those who only smoke cigarettes, a study shows.

Automated Insulin Delivery Cleared for Pregnant T1D Patients

The FDA has cleared Tandem’s Control-IQ technology as the first ever AID specifically for use in pregnancies complicated by type 1 diabetes.

Trial Setbacks May Delay Progress in Gonorrhea Prevention

The incidence of gonorrhea continues to rise across Europe, while recent vaccine trials show limited efficacy, raising concerns about prevention strategies.

Lilly's Obesity Pill Records Modest Second Week as Battle With Novo Intensifies

Eli Lilly's newly launched weight-loss pill had a modest second week, analysts said on Friday, as competition with ⁠Danish rival Novo Nordisk heats up in the oral obesity...